相关实验视频

Updated: Jun 23, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

在乳腺癌中有效向HER3的道路很长

Francesca Papa¹, Thomas Grinda², Elie Rassy²

¹Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Department of Medical Oncology, Florence University, Italy.

Cancer treatment reviews

|June 17, 2024

概括

人类表皮生长因子受体3 (HER3) 驱动乳腺癌的进展和抵抗. 新的针对HER3的疗法,如抗体药物合物,显示出有希望的结果,突出显示HER3的作用.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

乳腺癌是一种复杂的疾病,有多种不同的亚型,需要个性化治疗策略.
生物标志物识别对于定制乳腺癌治疗至关重要,但一些生物标志物的作用仍然不清楚.
人类表皮生长因子受体3 (HER3) 在乳腺癌中经常过度表达,并与进展有关.

研究的目的:

审查HER3在乳腺癌病原发生的所有亚型中的作用.
探索针对乳腺癌治疗中HER3的新兴治疗策略.
评估HER3检测对指导乳腺癌治疗的临床意义.

主要方法:

对乳腺癌中HER3研究的综合文献综述.
分析HER3在癌症进展,转移和耐药性的作用.
检查针对HER3向疗法的最新临床发现,包括抗体-药物合物.

主要成果:

在乳腺癌中,HER3过度表达是常见的 (50% - 70%) 并与较差的结果有关.
HER3信号传递对瘤生长,转移和对各种疗法的耐药性至关重要.
针对HER3的下一代抗体-药物结合体在临床前和临床研究中显示出令人鼓舞的疗效.

结论:

HER3 是乳腺癌进展的重要驱动因素,也是潜在的治疗点.
向HER3,特别是使用先进的抗体-药物联体,为治疗提供了一个有前途的途径.
HER3检测的临床实用性需要进一步研究,以优化乳腺癌管理.

关键词:

抗HER3药物抗HER3药物大脑转移是大脑的转移.乳腺癌是什么? 乳腺癌是什么在HER3中,HER3是HER3.帕里图马布-德鲁克斯可以.耐处理性耐处理性耐处理性

更多相关视频

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...